Sherlock Biosciences Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
33
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$28.3M
- Investors
-
2
Sherlock Biosciences General Information
Description
Developer of a diagnostic platform designed to control disease in low-resource settings. The company's platform uses engineering biology tools, including CRISPR and synthetic biology, to create a new generation of molecular diagnostics, enabling healthcare providers to rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Contact Information
Website
www.sherlock.bio(Operating Subsidiary)
Corporate Office
- 200 Talcott Avenue
- Watertown, MA 02472
- United States
Corporate Office
- 200 Talcott Avenue
- Watertown, MA 02472
- United States
Sherlock Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 19-Dec-2024 | $28.3M | Completed | Generating Revenue | ||
| 7. Grant | 06-Oct-2023 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 28-Feb-2022 | Completed | Generating Revenue | |||
| 5. Grant | 16-Dec-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 23-Apr-2019 | Completed | Startup | |||
| 2. Grant | 21-Mar-2019 | $17.5M | Completed | Startup | ||
| 1. University Spin-Out | 01-Mar-2019 | Completed | Startup |
Sherlock Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Sherlock Biosciences Comparisons
Industry
Financing
Details
Sherlock Biosciences Competitors (25)
One of Sherlock Biosciences’s 25 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| SomaGenics | Corporation | Santa Cruz, CA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Synthego | Venture Capital-Backed | Redwood City, CA | ||||
| Bio-Rad Laboratories | Corporation | Hercules, CA |
Sherlock Biosciences Patents
Sherlock Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026015653-A2 | Power-free fluidic device | Pending | 09-Jul-2024 | ||
| WO-2026015653-A3 | Power-free fluidic device | Pending | 09-Jul-2024 | ||
| EP-4720336-A1 | Condensed loop-mediated isothermal amplification | Pending | 01-Jun-2023 | ||
| WO-2024249878-A1 | Condensed loop-mediated isothermal amplification | Inactive | 01-Jun-2023 | ||
| AU-2024245317-A1 | In vitro diagnostic system | Pending | 31-Mar-2023 | B01L3/502715 |
Sherlock Biosciences Signals
Sherlock Biosciences Former Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 10X Capital | Venture Capital | Minority | ||
| A-Level Capital | Venture Capital | Minority | ||
| Albany Capital (Australia) | Venture Capital | Minority | ||
| Baidu Ventures | Corporate Venture Capital | Minority | ||
| Catalio Capital Management | Venture Capital | Minority |
Sherlock Biosciences Acquisitions (1)
Sherlock Biosciences’s most recent deal was a Merger/Acquisition with Sense Biodetection. The deal was made on 01-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sense Biodetection | 01-Feb-2023 | Merger/Acquisition | Diagnostic Equipment |
Sherlock Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sense Biodetection | Abingdon, United Kingdom | 2014 |
Sherlock Biosciences FAQs
-
When was Sherlock Biosciences founded?
Sherlock Biosciences was founded in 2019.
-
Where is Sherlock Biosciences headquartered?
Sherlock Biosciences is headquartered in Watertown, MA.
-
What is the size of Sherlock Biosciences?
Sherlock Biosciences has 33 total employees.
-
What industry is Sherlock Biosciences in?
Sherlock Biosciences’s primary industry is Diagnostic Equipment.
-
Is Sherlock Biosciences a private or public company?
Sherlock Biosciences is a Private company.
-
What is the current valuation of Sherlock Biosciences?
The current valuation of Sherlock Biosciences is .
-
What is Sherlock Biosciences’s current revenue?
The current revenue for Sherlock Biosciences is .
-
How much funding has Sherlock Biosciences raised over time?
Sherlock Biosciences has raised $113M.
-
Who are Sherlock Biosciences’s investors?
10X Capital, A-Level Capital, Albany Capital (Australia), Baidu Ventures, and Catalio Capital Management are 5 of 17 investors who have invested in Sherlock Biosciences.
-
Who are Sherlock Biosciences’s competitors?
Illumina, SomaGenics, Foundation Medicine, Synthego, and Bio-Rad Laboratories are some of the 25 competitors of Sherlock Biosciences.
-
When was Sherlock Biosciences acquired?
Sherlock Biosciences was acquired on 19-Dec-2024.
-
Who acquired Sherlock Biosciences?
Sherlock Biosciences was acquired by Orasure Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process